Joel Becker
Chief Executive Officer bei NEUROPACE, INC.
Vermögen: 692 604 $ am 31.03.2024
Profil
Joel D.
Becker is currently the Chief Executive Officer & Director at NeuroPace, Inc. He previously worked as the Chief Executive Officer at Xchangelabs LLC from 2017 to 2018, President-Americas Division at St. Jude Medical LLC from 2014 to 2016, President-CRM & Neuromodulation at Integer Holdings Corp.
from 2019 to 2022, and President at Viking North Ventures LLC from 2016 to 2019.
Becker received his undergraduate degree from Augustana College (Illinois) and his MBA from The Curtis L.
Carlson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEUROPACE, INC.
0,19% | 27.02.2024 | 52 470 ( 0,19% ) | 692 604 $ | 31.03.2024 |
Aktive Positionen von Joel Becker
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROPACE, INC. | Chief Executive Officer | 10.07.2023 |
Ehemalige bekannte Positionen von Joel Becker
| Unternehmen | Position | Ende |
|---|---|---|
| INTEGER HOLDINGS CORPORATION | Corporate Officer/Principal | 07.10.2022 |
| Viking North Ventures LLC | President | 01.04.2019 |
| Xchangelabs LLC | Chief Executive Officer | 01.08.2018 |
| ST JUDE MEDICAL INC | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Joel Becker
| Augustana College (Illinois) | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTEGER HOLDINGS CORPORATION | Health Technology |
| NEUROPACE, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
| Viking North Ventures LLC | |
| Xchangelabs LLC |
